» Articles » PMID: 22313123

Insulin Adherence Behaviours and Barriers in the Multinational Global Attitudes of Patients and Physicians in Insulin Therapy Study

Overview
Journal Diabet Med
Specialty Endocrinology
Date 2012 Feb 9
PMID 22313123
Citations 292
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To examine patient and physician beliefs regarding insulin therapy and the degree to which patients adhere to their insulin regimens.

Methods: Internet survey of 1250 physicians (600 specialists, 650 primary care physicians) who treat patients with diabetes and telephone survey of 1530 insulin-treated patients (180 with Type 1 diabetes, 1350 with Type 2 diabetes) in China, France, Japan, Germany, Spain, Turkey, the UK or the USA.

Results: One third (33.2%) of patients reported insulin omission/non-adherence at least 1 day in the last month, with an average of 3.3 days. Three quarters (72.5%) of physicians report that their typical patient does not take their insulin as prescribed, with a mean of 4.3 days per month of basal insulin omission/non-adherence and 5.7 days per month of prandial insulin omission/non-adherence. Patients and providers indicated the same five most common reasons for insulin omission/non-adherence: too busy; travelling; skipped meals; stress/emotional problems; public embarrassment. Physicians reported low patient success at initiating insulin in a timely fashion and adjusting insulin doses. Most physicians report that many insulin-treated patients do not have adequate glucose control (87.6%) and that they would treat more aggressively if not for concern about hypoglycaemia (75.5%). Although a majority of patients (and physicians) regard insulin treatment as restrictive, more patients see insulin treatment as having positive than negative impacts on their lives.

Conclusions: Glucose control is inadequate among insulin-treated patients, in part attributable to insulin omission/non-adherence and lack of dose adjustment. There is a need for insulin regimens that are less restrictive and burdensome with lower risk of hypoglycaemia.

Citing Articles

Dose Accuracy and Reliability of a Connected Insulin Pen System.

Backfish M, Kovalchick K, Albert R, Rosilio M, Chigutsa F, Liao B J Diabetes Sci Technol. 2025; :19322968241301760.

PMID: 39881439 PMC: 11780621. DOI: 10.1177/19322968241301760.


Subtypes of Insulin Restriction in Diabetes Management: A Systematic Review.

Beam A, Wiebe D Curr Diab Rep. 2025; 25(1):20.

PMID: 39869135 DOI: 10.1007/s11892-025-01577-3.


Using Oscillation to Improve the Insertion Depth and Consistency of Hollow Microneedles for Transdermal Insulin Delivery with Mechanistic Insights.

Smith F, Kotowska A, Fiedler B, Cerny E, Cheung K, Rutland C Mol Pharm. 2024; 22(1):316-329.

PMID: 39625848 PMC: 11707737. DOI: 10.1021/acs.molpharmaceut.4c00942.


Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults With Type 2 Diabetes in the Philippines: Results from a Prospective, Non-interventional, Real-World Study.

Nicodemus Jr N, Ang-Golangco N, Aquitania G, Ardena G, Dampil O, Fernando R J ASEAN Fed Endocr Soc. 2024; 39(2):61-69.

PMID: 39620193 PMC: 11604473. DOI: 10.15605/jafes.039.02.02.


Identifying the Relationship Between CGM Time in Range and Basal Insulin Adherence in People With Type 2 Diabetes.

Norlev J, Kronborg T, Jensen M, Vestergaard P, Hejlesen O, Hangaard S J Diabetes Sci Technol. 2024; :19322968241296828.

PMID: 39523580 PMC: 11571617. DOI: 10.1177/19322968241296828.


References
1.
Brod M, Kongso J, Lessard S, Christensen T . Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res. 2008; 18(1):23-32. DOI: 10.1007/s11136-008-9419-1. View

2.
Davidson M . Early insulin therapy for type 2 diabetic patients: more cost than benefit. Diabetes Care. 2004; 28(1):222-4. DOI: 10.2337/diacare.28.1.222. View

3.
Nakar S, Yitzhaki G, Rosenberg R, Vinker S . Transition to insulin in Type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers. J Diabetes Complications. 2007; 21(4):220-6. DOI: 10.1016/j.jdiacomp.2006.02.004. View

4.
Grant R, Wexler D, Watson A, Lester W, Cagliero E, Campbell E . How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists. Diabetes Care. 2007; 30(6):1448-53. PMC: 3829641. DOI: 10.2337/dc06-2499. View

5.
Peyrot M, Rubin R, Lauritzen T, Skovlund S, Snoek F, Matthews D . Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005; 28(11):2673-9. DOI: 10.2337/diacare.28.11.2673. View